U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07252336) titled 'A Multicenter Study of CAR-T Cells in Primary Ph+All' on Nov. 18.

Brief Summary: A Multicenter Study of CD19 CAR-T Cells in the Treatment of Adult Patients With Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia

Intervention: DRUG: CD19 CAR-T cells

Each subject receive CD19/CD22 CAR T-cells by intravenous infusion

Recruitment Status: RECRUITING

Sponsor: Zhejiang University

Information provided by (Responsible Party): He Huang, Zhejiang University

Disclaimer: Curated by HT Syndication....